NS · Healthcare

Kimia Biosciences Ltd (530313)

Pharmaceuticals & Biotechnology

Kimia Biosciences Ltd (530313) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $1.56B, P/E ratio is 21.02, net margin is 3.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 530313

Market cap

$1.56B

P/E ratio

21.02

Net margin

3.1%

Kimia Biosciences Ltd (530313) — FAQ

What is Kimia Biosciences Ltd's market cap?

Kimia Biosciences Ltd (530313) has a reported market cap of $1.56B (data as of 2026-07-10).

What is 530313's P/E ratio?

The price-to-earnings (P/E) ratio for Kimia Biosciences Ltd (530313) is 21.02 (data as of 2026-07-10).

Does Kimia Biosciences Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Kimia Biosciences Ltd (530313). Check the MyAverix Finance app for the latest dividend data.

What sector is Kimia Biosciences Ltd in?

Kimia Biosciences Ltd (530313) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is 530313 listed on?

530313 is listed on NS.

What is Kimia Biosciences Ltd's net margin?

Kimia Biosciences Ltd (530313) reports a net margin of 3.1% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)